Literature DB >> 34026439

Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy.

Runqi Zhu1,2, Tianqun Lang1,2,3, Wenlu Yan1,2, Xiao Zhu1,2, Xin Huang1,2, Qi Yin1,2,3, Yaping Li1,2,3,4.   

Abstract

Gut microbiota have close interactions with the host. It can affect cancer progression and the outcomes of cancer therapy, including chemotherapy, immunotherapy, and radiotherapy. Therefore, approaches toward the modulation of gut microbiota will enhance cancer prevention and treatment. Modern drug delivery systems (DDS) are emerging as rational and promising tools for microbiota intervention. These delivery systems have compensated for the obstacles associated with traditional treatments. In this review, the essential roles of gut microbiota in carcinogenesis, cancer progression, and various cancer therapies are first introduced. Next, advances in DDS that are aimed at enhancing the efficacy of cancer therapy by modulating or engineering gut microbiota are highlighted. Finally, the challenges and opportunities associated with the application of DDS targeting gut microbiota for cancer prevention and treatment are briefly discussed.
© 2021 The Authors. Advanced Science published by Wiley‐VCH GmbH.

Entities:  

Keywords:  cancer therapy; carcinogenesis; drug delivery system; gut microbiota; modulation

Mesh:

Year:  2021        PMID: 34026439      PMCID: PMC8132165          DOI: 10.1002/advs.202003542

Source DB:  PubMed          Journal:  Adv Sci (Weinh)        ISSN: 2198-3844            Impact factor:   16.806


  250 in total

1.  Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1.

Authors:  Mara Roxana Rubinstein; Jung Eun Baik; Stephen M Lagana; Richard P Han; William J Raab; Debashis Sahoo; Piero Dalerba; Timothy C Wang; Yiping W Han
Journal:  EMBO Rep       Date:  2019-03-04       Impact factor: 8.807

2.  The human gut bacterial genotoxin colibactin alkylates DNA.

Authors:  Matthew R Wilson; Yindi Jiang; Peter W Villalta; Alessia Stornetta; Paul D Boudreau; Andrea Carrá; Caitlin A Brennan; Eunyoung Chun; Lizzie Ngo; Leona D Samson; Bevin P Engelward; Wendy S Garrett; Silvia Balbo; Emily P Balskus
Journal:  Science       Date:  2019-02-15       Impact factor: 47.728

3.  Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota.

Authors:  Haitao Chen; Fan Zhang; Rongrong Li; Yu Liu; Xuanying Wang; Xinjie Zhang; Chao Xu; Yan Li; Yong Guo; Qinghua Yao
Journal:  Biomed Pharmacother       Date:  2020-01-17       Impact factor: 6.529

Review 4.  Role of the NF-κB signaling pathway in the pathogenesis of colorectal cancer.

Authors:  Atena Soleimani; Farzad Rahmani; Gordon A Ferns; Mikhail Ryzhikov; Amir Avan; Seyed Mahdi Hassanian
Journal:  Gene       Date:  2019-12-03       Impact factor: 3.688

5.  Genetic alterations in colorectal cancer.

Authors:  Tannaz Armaghany; Jon D Wilson; Quyen Chu; Glenn Mills
Journal:  Gastrointest Cancer Res       Date:  2012-01

6.  Metabolic Model-Based Integration of Microbiome Taxonomic and Metabolomic Profiles Elucidates Mechanistic Links between Ecological and Metabolic Variation.

Authors:  Cecilia Noecker; Alexander Eng; Sujatha Srinivasan; Casey M Theriot; Vincent B Young; Janet K Jansson; David N Fredricks; Elhanan Borenstein
Journal:  mSystems       Date:  2016-01-19       Impact factor: 6.496

7.  Clinical significance of Fusobacterium nucleatum, epithelial-mesenchymal transition, and cancer stem cell markers in stage III/IV colorectal cancer patients.

Authors:  Xuebing Yan; Liguo Liu; Hao Li; Huanlong Qin; Zhenliang Sun
Journal:  Onco Targets Ther       Date:  2017-10-17       Impact factor: 4.147

8.  Bioinspired oral delivery of gut microbiota by self-coating with biofilms.

Authors:  Xinyue Wang; Zhenping Cao; Mengmeng Zhang; Lu Meng; Zunzhen Ming; Jinyao Liu
Journal:  Sci Adv       Date:  2020-06-24       Impact factor: 14.136

Review 9.  Fantastic voyage: the journey of intestinal microbiota-derived microvesicles through the body.

Authors:  Régis Stentz; Ana L Carvalho; Emily J Jones; Simon R Carding
Journal:  Biochem Soc Trans       Date:  2018-08-28       Impact factor: 5.407

10.  Fusobacterium nucleatum Aggravates the Progression of Colitis by Regulating M1 Macrophage Polarization via AKT2 Pathway.

Authors:  Le Liu; Liping Liang; Huifen Liang; Mingming Wang; Bingyun Lu; Meng Xue; Jun Deng; Ye Chen
Journal:  Front Immunol       Date:  2019-06-12       Impact factor: 7.561

View more
  4 in total

1.  Yishen Qingli Heluo Granule Ameliorates Renal Dysfunction in 5/6 Nephrectomized Rats by Targeting Gut Microbiota and Intestinal Barrier Integrity.

Authors:  Xian Sun; Jie Chen; Yiting Huang; Sha Zhu; Shuaishuai Wang; Zijing Xu; Junfeng Zhang; Wei Sun
Journal:  Front Pharmacol       Date:  2022-06-22       Impact factor: 5.988

2.  Effects of Docetaxel Injection and Docetaxel Micelles on the Intestinal Barrier and Intestinal Microbiota.

Authors:  Qingya Liu; Yi Lu; Yao Xiao; Liping Yuan; Danrong Hu; Ying Hao; Ruxia Han; Jinrong Peng; Zhiyong Qian
Journal:  Adv Sci (Weinh)       Date:  2021-10-28       Impact factor: 16.806

3.  Prebiotics and Postbiotics Synergistic Delivery Microcapsules from Microfluidics for Treating Colitis.

Authors:  Keli Yang; Xiaocheng Wang; Rongkang Huang; Hui Wang; Ping Lan; Yuanjin Zhao
Journal:  Adv Sci (Weinh)       Date:  2022-04-11       Impact factor: 17.521

Review 4.  Impact of microbiota-immunity axis in pancreatic cancer management.

Authors:  Ilenia Bartolini; Giulia Nannini; Matteo Risaliti; Francesco Matarazzo; Luca Moraldi; Maria Novella Ringressi; Antonio Taddei; Amedeo Amedei
Journal:  World J Gastroenterol       Date:  2022-08-28       Impact factor: 5.374

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.